Full Text View
Tabular View
No Study Results Posted
Related Studies
Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years
This study has been terminated.
( Results of the interim analysis suggested no significant diff between study groups. )
Study NCT00353184   Information provided by Washington University School of Medicine
First Received: July 17, 2006   Last Updated: February 23, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Asthma
More general conditions related to this trial
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases
Additional drug interventions recognized in this trial
Montelukast
More general drug interventions related to this trial
Anti-Asthmatic Agents
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Leukotriene Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Washington University School of Medicine
American Academy of Pediatrics
Ambulatory Pediatric Association


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services